SCHEMBL1131591

SCHEMBL1131591

COC(=O)C=Cc1nn(C2CCCCC2)c(-c2ccc(OCc3ccccc3)cc2)c1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMKLR1 Q99788 4/20 0.39
BTK Q06187 3/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
GSK3B P49841 1/20 0.39
BACE1 P56817 1/20 0.39
KCNJ6 P48051 2/20 0.38
KCNJ3 P48549 2/20 0.38
KCNJ5 P48544 1/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 1/20 0.38
RAB9A P51151 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CNR1 P21554 1/20 0.37
ALOX5 P09917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131587 1.00 CMKLR1 (0.39) CMKLR1BTKPTGS1PTGS2GSK3B
SCHEMBL1131332 0.91 PTGS1 (0.41) CMKLR1BTKPTGS1PTGS2GSK3B
SCHEMBL1132052 0.91 PTGS1 (0.41) CMKLR1BTKPTGS1PTGS2GSK3B
SCHEMBL1132022 0.90 CMKLR1 (0.41) CMKLR1BTKGSK3BBACE1KCNJ6
SCHEMBL1131853 0.85 BTK (0.42) CMKLR1BTKKDM4ESMN1; SMN2KMT2A
SCHEMBL1132086 0.84 HRH3 (0.41) CMKLR1BTKALOX5
SCHEMBL12860095 0.82 CNR1 (0.46) CMKLR1BTKPTGS1PTGS2GSK3B
SCHEMBL1131279 0.81 FABP3 (0.44) CMKLR1BTKPTGS2GSK3BBACE1
SCHEMBL1131274 0.81 FABP3 (0.44) CMKLR1BTKPTGS2GSK3BBACE1
SCHEMBL1131696 0.81 KDM4E (0.43) CMKLR1BTKKDM4ESMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP claimed
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed